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The primary structure of a gene of the Na +,K+-ATPase multigenic family in the human genome has been determined. 
The gene corresponds to a hypothetical ~dlI-form of the enzyme catalytic subunit. The gene comprises over 25000 bp, 
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1. INTRODUCTION 
Integral membrane protein Na+,K+-ATPase 
performs the active transport of Na + and K + 
across the cellular membranes. We determined 
complete primary structures of cDNA of both (~r 
and/Y) enzyme subunits from pig kidney [1-3]. 
While studying the structure of the human genome 
locus encoding the enzyme, we discovered the 
family of related genes coding for the proteins 
homologous to the enzyme catalytic subunit [4,5] 
and showed a tissue-specific character of regula- 
tion of the expression level of these genes [6]. The 
paper presents the primary structure of one of the 
genes of this family that correlates to ~rIII-form ac- 
cording to the nomenclature proposed in [7]. Parts 
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of the present data have been published earlier 
[4,5,8,9]. 
2. MATERIALS AND METHODS 
Recombinant phages ANKaR 10-3 and A NKotR3-2 (fig. 1) were 
identified and analysed as described [4]. A new genomic library 
was constructed to find out the N-terminal part of the gene. 
DNA was isolated from human brain as in [10]. After partial 
cleavage of the genomic DNA with Sau3A endonuclease and 
centrifugation in the sucrose density gradient, the DNA 
fragments ranging between 10000 and 20000 bp were cloned in- 
to the BamHI site of vector AEMBL3 [11]. The library (3 x 106 
independent clones) was screened by hybridization to the exon 
fragment (coordinates 361-441) from the genomic insert of 
ANKotR3-2 recloned into phage MI3. 
Restriction mapping of the positive clones revealed that the 
genomic insert of ANKotRMI overlapped with that of 
ANKaR3-2 [4]. Random fragments of the ANKaRM1 obtained 
by sonication were cloned into phage M 13mp 18 and sequenced 
according to Sanger [12] in both directions. Determination of
the primary structure confirmed the complete correlation of 
nucleotide sequences of the ANKo~RM1 and ANKctR3-2 inserts 
in their overlapping region. The human brain cDNA library in 
pBR322 was screened by hybridization to the probes: (i) nick- 
translated PstI fragment of plasmid pB2801 (which codes for 
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the pig kidney enzyme o~-subunit with coordinates 1545-2880) 
[3,4]; (ii) synthetic oligonucleotide corresponding to coor- 
dinates 7-31 of the studied gene. 
3. RESULTS AND DISCUSSION 
The physical map of the gene of the human 
Na+,K÷-ATPase catalytic subunit is given in fig. 1; 
its sequence in fig.2. 
The gene comprises more than 25000 bp in 
length and its protein-coding region consists of 23 
exons and 22 introns. The primary structure of ex- 
ons 2-4 and 14-23 is completely identical to the 
sequences of eDNA fragments isolated from the 
human brain eDNA library. Comparison of the se- 
quences of the gene and eDNA shows that the in- 
tron preceding exon 2 separates it from the 
5'-untranslated region and 6 nucleotides encoding 
the first two amino acid residues (Met-Gly) of the 
protein-precursor. Since we have not identified the 
genomic sequence corresponding to this eDNA 
part, the exact size of exon 1 is unknown. It is 
noteworthy, in the gene sequence stablished by us 
that codes for the cr + -form of the 
Na ÷,K÷-ATPase catalytic subunit exon 1 includes 
the extended part of the 5'-untranslated region 
and first 4 codons of the protein-precursor [9]. Ex- 
cept for exon 1 and exon 23, which includes 26 pro- 
tein coding base pairs, the stop codon (TGA) and 
the entire 3'-untranslated region (548 bp), all 
other exons contain only protein-coding sequences 
ranging between 60 and 269 bp with a medium size 
of 143 bp. This accords well with the Blake cor- 
relation [13] establishing 2-3 exons per 100 amino 
acid residues on an average. The intron lengths 
range between 70 and 5000 bp. Among the introns, 
12 occur between codons, 6 interrupt at frame 1, 
and 4 at frame 2. Of other gene characteristics, the 
presence of a polyadenylation oncanonic site 
AATATA located 15-17 nucleotides upstream 
from the poly(A) attachment site (see legend to 
fig.2) deserves pecial attention. The site of the 
similar structure was observed in one of the SV-40 
mutants with the markedly decreased ability of 
polyadenylation of mRNA [14]. Several Alu 
repeats were revealed in intron regions. The detail- 
ed analysis of these and other peculiarities will be 
published elsewhere. Table 1 shows consensus e- 
quences of 5'-  and 3'-splice sites determined for 
a, III-form of the human enzyme gene. The consen- 
sus derived coincides with that described in 
literature [15]. 
The sequences we established for the gene and 
eDNA are highly homologous to eDNA of aIII- 
form of the catalytic subunit from rat brain [7]. 
Homology between the derived amino acid se- 
quences is even more evident, while homology of 
the primary structure of the gene and cDNAs cor- 
responding to other isoforms of the rat a~-subunit 
is less. Therefore the sequence published most 
probably represents he gene coding for cdII-form 
of the human Na÷,K÷-ATPase catalytic subunit. 
Though the sequence of the corresponding mRNA 
possesses necessary translation start and stop 
signals, it is still unclear whether this protein exists 
in the cell. If this is the case, it may be a new form 
of the Na÷,K÷-ATPase catalytic subunit. One can- 
not exclude the possibility that this subunit prin- 
cipally belongs to another ion-transporting 
ATPase. 
As mentioned previously, expression of the 
studied gene is tissue-specific and more intense in 
human kidney and brain [6]. (The same paper in- 
dicates the differences in hybridization patterns of 
Southern blots of DNA isolated from different 
tissues. Further analysis showed that this 
phenomenon is probably not universal, and its 
origin remains obscure.) 
The derived amino acid sequence of the primary 
product of the gene translation consists of 1013 
amino acid residues (molecular mass 111688 Da). 
Its comparison with the known structures of 
analogous subunits of other Na÷,K÷-ATPases 
unravels the following specific features. It is ten 
residues horter than the precursor of the catalytic 
subunit of the enzyme (or-form) from HeLa cells 
[16]. The total number of amino acid distinctions 
in these proteins is 139, of them 32 are concen- 
trated in the N-terminus, the most variable part of 
E1E2 ion-transporting ATPases (residues 1-59), 
the sequence of the first 11 residues completely dif- 
fers from the corresponding regions of other 
forms. The second cluster of variability (residues 
478-487) directly precedes the lysine residue 
modified with fluorescein isothiocyanate [17,18] 
and probably pertains to the ATP-hydrolysing site. 
The homology degree of the remaining regions of 
the compared polypeptides i -90%.  
The number of the differences between the 
described structure and rat aI I I  sequence [7,19] is 
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Fig. 1. Structural organization of the gene for trill-form of the human Na+,K+-ATPase catalytic subunit. Exons 1-23 are designated 
by vertical bars. The figures above indicate the ordinal number of the first nucleotide in exons. Restriction maps of overlapping clones 
are given below, figures indicate fragment lengths in kb. E, EcoRI; B, Barn|l; H, HindlIl. 
10. This demonstrates that the gene coding for the 
aII! protein appeared before the divergence of the 
primate and rodent lineages during evolution. 
The possible relation of the exon-intron 
organization of the gene and structure-functional 
features of the Na+,K+-ATPase catalytic subunit 
can be considered in the light of the hypothesis on 
correspondence b tween the exons and functional 
or structural protein domains [20-22]. 
At present, the structures of several animal ion- 
transporting ATPases of the E~E2 type - 
Na+,K+-ATPases [1,3,7,9,16,19,23,24], H+,K +- 
ATPase [25], and Ca2+-ATPases [26] - are defined 
by analysis of cDNA nucleotide sequences. Com- 
parison of the known primary structures including 
that described above revealed several structural 
regions highly conservative among all these related 
enzymes. These regions designated in fig.2 have 
the following coordinates: 168-195 (exon 6), 
200-210 (exon 7), 223-282 (exons 7-8), 313-379 
(exons 8-9), 437-444 (exon ll), 495-524 (exon 
12), 574-635 (exons 13-14), 678-775 (exons 
15-17), 793-828 (exons 17-18) and 971-998 (exon 
22). Except for the two latter portions, others are 
in hydrophilic regions linking membrane segments 
II and III, IV and V. According to the structural 
model of the Na+,K+-ATPase catalytic subunit 
they are located in the cytoplasmic region of the 
enzyme [27,28]. Homologous portions 313-379, 
495-524 and 678-775 include all the known com- 
ponents of the enzyme ATP-hydrolyzing site which 
are Asp-364, Lys-496, Asp-705, Asp-709 and 
Lys-714 in this sequence. Here the homology ex- 
tent is maximal. Undoubtedly, all the homologous 
regions (among them those not ascribed to any 
function yet) form the spatially interrelated struc- 
tural basis of E~E2-ATPases activity [28]. 
Positions of introns 5,6,9-12,14,21,22 coincide 
with the boundaries of a series of the above men- 
tioned homologous regions of ion-transporting 
ATPases. However, other introns (7,8,13,15-17) 
appear to fall into the conservative s quences. 
Comparison of the structures of the catalytic 
subunits of various Na+,K+-ATPases shows that 
position of intron 3 correlates with the boundary 
of the most variable N-terminal region encoded by 
the first exons. In the same way, introns 9 and 10 
clearly mark the variable part of the structures 
coded by exon 10. A number of clusters of non- 
conservative r sidues are localized at the beginning 
of exons 12,13,15. On the contrary, in case of exon 
19 the variable part is in its middle. 
Positions of the identified introns, except for in- 
tron 1 [9], in different genes of the multigenic 
family coincide [5]. This fact implies rather similar 
intron-exon structural organization for all the 
known genes in the multigenic family including 
those for Na+,K +- and H+,K+-ATPases [5,29] and 
demonstrates their origin to be the common 
primordial gene. 
Certain relations are traced when comparing the 
exon-intron structure of the analysed gene and the 
model for the transmembrane organization of the 
a-form of the Na+,K+-ATPase catalytic subunit 
based upon the data of limited proteolysis [27,28], 
immunochemical analysis [30] and differentiated 
89 













CCCGCCTGGCTCTCTCGCCGGAGCCGCCAAG ATG GGG . . . . . . . . . .  in t ron  I . . . . . . . . . .  ATCGCCACCTCGCAG GAC AAG AAA GAT 
Met -G ly  Asp-Lys -Lys -Asp-  
GAC AAG GAC TCA CCC AAG AAG AAC AAG GGC AAG GAG CGC CGG GAC CTG GAT GAC CTC AAG AAG GAG GTG GCT ATG 
As•-Lys -Asp-Ser -P r• -Lys -Lys -Asn-Lys -G•y-Lys -G•u-Arg -Arg -Asp-Leu-Asp-Asp-Leu-Lys -Lys -G•u-Va•-A•a-Met  
GTAAGCCTCGCCCTC . . . . . . . . . .  in t ron  2 (99b.p.)  . . . . . . . . . .  ACTCCTGTTCCTCAG ACA GAG CAC AAG ATG TCA GTG GAA 
Thr -G lu -H is -Lys -Met -Ser -Va l -G lu -  
GAG GTC TGC CGG AAA TAC AAC ACA GAC TGT GTG CAG GTGTGGCCAGGCTGT . . . . . . . . . .  in t ron  3 . . . . . . . . . .  GTCCTCTGTC 
G lu -Va l -Cys -Arg -Lys -Tyr -Asn-Thr -Asp-Cys -Va l -G ln  
CCTAG GGT TTG ACC CAC AGC AAA GCC CAG GAG ATC CTG GCC CGG GAT GGG CCT AAC GCA CTC ACG CCA CCG CCT ACC 
G•y-Leu-Thr -H is -Ser -Lys -A•a-G•n-G•u- I•e -Leu-A•a-Arg -Asp-G•y-Pr• -Asn-A•a-Leu-Thr -P r• -Pr• -Pr• -Thr -  
ACC CCA GAG TGG GTC AAG TTT  TGC CGG CAG CTC TTC GGG GGC TTC TCC ATC CTG CTG TGG ATC GGG GCT ATC CTC 
Thr -P r• -G•u-Trp -Va•-Lys -Phe-Cys -Arg -G•n-Leu-Phe-G•y-G•y-Phe-Ser - I•e -Leu-Leu-Trp - I•e -G•y-A•a- I•e -Leu-  
TGC TTC CTG GCC TAC GGT ATC CAG GCG GGC ACCGAG GAC GAC CCC TCT GGT GAC AAC GTGAGTGCCTGGACC . . . . . . . . . .  
Cys -Phe-Leu-A la -Tyr -G ly - I le -G ln -A la -G ly -ThrG lu -Asp-Asp-Pro -Ser -G ly -Asp-Asn  
. . . in t ron  4 . . . . . . . . . .  CACATCTCCCCACAG CTG TAC CTG GGC ATC GTG CTG GCG GCC GTG GTG ATC ATC ACT GGC TGC 
Leu-Tyr -Leu-G ly - I le -Va l -Leu-A la -A la -Va l -Va l - I l e - I le -Thr -G ly -Cys -  
TTC TCC TAC TAC CAG GAG GCC AAG AGC TCC AAG ATC ATG GAG TCC TTC AAG AAC ATG GTG CCC CAG GTGAAGGGTGCC 
Phe-Ser -Tyr -Tyr -G ln -G•u-A•a-Lys -Ser -Ser -Lys - I•e -Met -G•u-Ser -Phe-Lys -Asn-Met -Va•-Pr• -G•n 
CAG . . . . . . . . . .  in t ron  5 (113b.p.)  . . . . . . . . . .  TCCATCCCACCTCAG CAA GCC CTG GTG ATC CGG GAA GGT GAG AAG ATG 
G ln -A la -Leu-Va l - I l e -Arg -G lu -G ly -G lu -Lys -Met -  
CAG GTG AAC GCT GAG GAG GTG GTG GTC GGG GAC CTG GTG GAG ATC AAG GGT GGA GAC CGA GTG CCA GCT GAC CTG 










CGG ATC ATC TCA GCC CAC GGC TGC AAG GTGGGCCTGTAGGGC . . . . . . . . . .  in t ron  6 (433b.p.)  . . . . . . . . . .  TGCACCTACCC 
Arg- I le - I le -Ser -A la -H is -G ly -Cys -Lys  
CCAG GTG GAC AAC TCC TCC CTG ACT GGC GAA TCC GAG CCC CAG ACT CGC TCT CCC GAC TGC ACG CAC GAC AAC CCC 
Va~-AsP-Asn-Ser -Ser -Leu-Thr -G ly -G~u-Ser -G~u-Pr~-G~n-Thr -Arg -Ser -P r~-Asp-Cys -Thr -H is -Asp-Asn-Pr~-  
TTG GAG ACT CGG AAC ATC ACCTTC TTT  TCC ACC AAC TGT GTG GAA G GTGAGGCGGGTGCAG . . . . . . . . .  in t ron  7 (115 b.p. )  
Leu-G lu -Thr -Arg -Asn- I le -Thr -Phe-Phe-Ser -Thr -Asn-Cys -Va l -G lu -G( ly )  
. . . . . . . . . .  CCCTCTGGCCTGCAG GC ACG GCT CGG GGC GTG GTG GTG GCC ACG GGC GAC CGC ACT GTC ATG GGC CGT ATC 
(G) ly -Thr -A la -Arg -G ly -Va l -Va l -Va l -A la -Thr -G ly -Asp-Arg -Thr -Va l -Met -G ly -Arg - I le -  
GCC ACC CTG GCA TCA GGG CTG GAG GTG GGC AAG ACG CCC ATC GCC ATC GAG ATT  GAG CAC TTC ATC CAG CTC ATC 
A•a-Thr -Leu-A•a-Ser -G•y-Leu-G•u-Va•-G•y-Lys -Thr -P r• - I•e -A•a- I•e -G•u- I•e -G•u-H is -Phe- I•e -G•n-Leu- I•e -  
ACC GGC GTG GCT GTC TTC CTG GGT GTC TCC TTC TTC ATC CTC TCC CTC ATT  CTC GGA TAC ACC TGG CTT  GAG GCY 
Thr -G•y-Va•-A•a-Va•-Phe-Leu-G•y-va•-Ser -Phe-Phe- I•e -Leu-Ser -Leu- I•e -Leu-G•y-Tyr -Thr -Trp -Leu-G•u-A•a-  
GTC ATC TTC CTC ATC GGC ATC ATC GTG GCC AAT GTC CCA GAG GGT CTG CTG GCC ACT GTC ACT GTAAGGCCAGGCTCC .... 
Va~- I~e-Phe-Leu- I~e-G~y- I~e- I~e-va~-A~a-Asn-Va] . .P r~-G~u-G~y-Leu-Leu-A~a-Thr -Va~-Thr  
. . . . . . . .  in t ron  8 . . . . . . . . . .  TTGCTCGTCCTCCAG GTG TGT CTG ACC GTG ACC GCC AAG CGC ATG GCC CGG AAG AAC TGC 
Va l -Cys -Leu-Thr -Va l -Thr -A la -Lys -Arg -Met -A la -Arg -Lys -Asn-Cys -  
CTG GTG AAG AAC CTG GAG GCT GTA GAG ACC CTG GGC TCC ACG TCC ACC ATC TGC TCA GAT AAG ACA GGG ACC CTC 









ACT CAG AAC CGC ATG ACA GTC GCC CAC ATG TGG TTT  GAC AAC CAG ATC CAC GAG GCT GAC ACC ACT GAG GAC CAG 
Thr-G•n-Asn-Arg-Met-Thr-Va•-A•a-His-Met-Trp-Phe-Asp-Asn-G•n-I•e-His-G•u-A•a-Asp-Thr-Thr-G•u-Asp-G•n- 
TCA G GTGAGCGCAGGCCCC . . . . . . . . . .  in t ron  9 (74b.p.)  . . . . . . . . . .  ACATGCCTCCCCCAG GG ACC TCA TTT  GAC AAG AGT 
Ser -G( ly )  (G) ly -Thr -Ser -Phe-Asp-Lys -Ser -  
TCG CAC ACC TGG GTG GCC CTG TCT CAC ATC GCT GGG CTC TGC AAT CGC GCT GTC TTC AAG GGT GGT CAG GAC AAC 
Ser -H is -Thr -Trp -Va•-A•a-Leu-Ser -H is - I•e -A•a-G•y-Leu-Cys -Asn-Arg -A•a-Va•-Phe-Lys -G•y-G•y-G•n-Asp-Asn-  
ATC CCT GTG CTC AAG AG GTGGGTTAGCTACTG . . . . . . . . . .  in t ron  10 (84b.p.)  . . . . . . . . . .  CCTTTCTCCTTGCAG G GAT GTG 
I le -P ro -Va l -Leu-Lys -Ar (g )  (Ar )g -Asp-Va l -  
GCT GGG GAT GCG TCT GAG TCT GCC CTG CTC AAG TGC ATC GAG CTG TCC TCT GGC TCC GTG AAG CTG ATG CGT GAA 
A•a-G•y-As•-A•a-Ser -G•u-Ser -A•a-Leu-Leu-Lys -Cys - I•e -G•u-Leu-Ser -Ser -G•y-Ser -Va•-Lys -Leu-Met -Arg -G•u-  
CGA AAC AAG AAA GTG GCT GAG ATT  CCC TTC AAT TCC ACC AAC AAA TAC CAG GTACTCTGGCTTTCC . . . . . . . . . .  in t ron  11.. 
A rg -Asn-Lys -Lys -Va l -A la -G lu - I le -P ro -Phe-Asn-Ser -Thr -Asn-Lys -Tyr -G ln  
. . . . . . . .  CTGATCGGTCCCCAG CTC TCC ATC CAT GAG ACC GAG GAC CCC AAC GAC AAC CGA TAC CTG CTG GTG ATG AAG GGT 
Leu-Ser - I•e -H is -G•u-Thr -G•u-Asp-Pr• -Asn-Asp-Asn-Arg -Tyr -Leu-Leu-va•-Met -Lys -G•y-  
GCC CCC GAG CGC ATC CTG GAC CGC TGC TCC ACC ATC CTG CTA CAG GGC AAG GAG CAG CCT CTG GAC GAG GAA ATG 








AAG GAG GCC TTT  CAG AAT GCC TAC CTT  GAG CTC GGT GGC CTG GGC GAG CGC GTG CTT  G GTGCGAGGTGC . . . . . . . . . . . .  
Lys -G•u-A•a-Phe-G•n-Asn-A•a-Tyr -Leu-G•u-Leu-G•y-G•y-Leu-G•y-G•u-Arg -Va•-Leu-G(•y)  
. . in t ron  12 . . . . . . . . . .  CTTCCCTGCCACTAG GT TTC TGC CAT TAT  TAC CTG CCC GAG GAG CAG TAT CCC CAA GGC TTT  
(G) ly -Phe-Cys -H is -Tyr -Tyr -Leu-Pro -G lu -G lu -G ln -Tyr -P ro -G ln -G ly -Phe-  
GCC TTC GAC TGT GAT GAC GTG AAC TTC ACC ACG GAC AAC CTC TGC TTT  GTG GGC CTC ATG TCC ATG ATC GGC CCA 
A•a-Phe-Asp-Cys -Asp-Asp-Va•-Asn-Phe-Thr -Thr -Asp-Asn-Leu-Cys -Phe-Va•-G•y-Leu-Met -Ser -Met - I•e -G•y-Pr• -  
CCC CGG GCA GCC GTC CCT GAC GCG GTG GGC AAG TGT CGC AGC GCA GGC ATC AAG GTGTGGCTTGGGTGC . . . . . . . . . .  in t ron  
Pro -Arg -A la -A la -Va l -P ro -Asp-A la -Va l -G ly -Lys -Cys -Arg -Ser -A la -G ly - I le -Lys  
13 (70b.p.)  . . . . . . . . . .  AAACAATGCCTGCAG GTC ATC ATG GTC ACC GGC GAT CAC CCC ATC ACG GCC AAG GCC ATT  GCC 
Va l - I l e -Met -Va l -Thr -G ly -Asp-H is -P ro - I le -Thr -A la -Lys -A la - I le -A la -  
AAG GGT GTG GGC ATC ATC TCT GAG GGC AAC GAG ACT GTG GAG GAC ATC GCC GCC CGG CTC AAC ATT  CCC GTC AGC 
Lys -G•y-Va•-G•y- I•e - I•e -Ser -G•u-G•y-Asn-G•u-Thr -Va•-G•u-Asp- I•e -A•a-A la -Arg -Leu-Asn- I•e -Pr• -va•-Ser -  
CAG GTT AAC CCC CG GTGAGCCACCCATTC . . . . . . . . . .  in t ron  14 . . . . . . . . . .  CTCTGCTCTTCCCAG G GAT GCC AAG GCC TGC 
G ln -Va l -Asn-Pro -Ar (g )  (Ar )g -Asp-A la -Lys -A la -Cys -  
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GTG ATC CAC GGC ACC GAC CTC AAG GAC TTC ACC TCC GAG CAA ATC GAC GAG ATC CTG CAG AAT CAC ACC GAG ATC 
va•- I•e -H is -G•y-Thr -As• -Leu-L•s -Asp-Phe-Thr -Ser -G•u-G•n- I•e -Asp-G•u- I•e -Leu-G•n-Asn-H is -Thr -G•u- I•e -  
GTC TTC GCC CGC ACA TCC CCC CAG CAG AAG CTC ATC ATT  GTG GAG GGC TGT CAG AGA CAG GTGGGCTGCGCTCCC . . . . . .  
Va l -Phe-A la -Arg -Thr -Ser -P ro -G ln -G ln -Lys -Leu- I le - I le -Va l -G lu -G ly -Cys -G ln -Arg -G ln  
.... in t ron  15 . . . . . . . . . .  ACCCTCTCTCCCCAG GGT GCA ATT  GTG GCT GTG ACC GGG GAT GGT GTG AAC GAC TCC CCC GCT 
G ly -A la - I le -Va l -A la -Va l -Thr -G ly -Asp-G ly -Va l -Asn-Asp-Ser -P ro -A la -  
CTG AAG AAG GCC GAC ATT  GGG GTG GCC ATG GGC ATC GCT GGC TCT GAC GTC TCC AAG CAG GCA GCT GAC ATG ATC 
Leu-Lys -Lys -A•a-As•- I•e -G•y-Va•-A•a-Met -G•y- I•e -A•a-G•y-Ser -As• -Va•-Ser -Lys -G•n-A•a-A•a-As•-Met - I•e -  
CTG CTG GAC GAC AAC TTT  GCC TCC ATC GTC ACA GGG GTG GAG GAG G GTGAGTTGGCCAGGG . . . . . . . . . .  in t ron  16 ..... 
Leu-Leu-Asp-Asp-Asn-Phe-A la -Ser - I le -Va l -Thr -G ly -Va l -G lu -G lu -G( ly )  
. . . . . .  CTGCCTGTGCCACAG GC CGC CTG ATC TTC GAC AAC CTA AAG AAG TCC ATT  GCC TAC ACC CTG ACC AGC AAT ATC 
(G) ly  Arg -Leu- I le -Phe-Asp-Asn-Leu-Lys -Lys -Ser - I le -A la -Tyr -Thr -Leu-Thr -Ser -Asn- I le -  
CCG GAG ATC ACG CCC TTC CTG CTG TTC ATC ATG GCC AAC ATC CCG CTG CCC CTG GGC ACC ATC ACC ATC CTC TGC 
Pr• -G•u- I•e -Thr -P r• -Phe-Leu-Leu-Phe- I•e -Met -A•a-Asn- I•e -Pr• -Leu-Pr• -Leu-G•y-Thr - I•e -Thr - I•e -Leu-Cys -  
ATC GAT CTG GGC ACT GAC ATG GTGAGCCCTGGCAGC . . . . . . . . . .  in t ron  17 (77b.p.)  . . . . . . . . . .  GCCTCCTCCGCCTAG GTC 
I le -Asp-Leu-G ly -Thr -Asp-Met  Va l -  
CCT  GCC ATC TCA CTG GCG TAC GAG GCT GCC GAA AGC GAC ATC ATG AAG AGA CAG CCC AGG AAC CCG CGG ACG GAC 












AAA TTG GTC AAT GAG AGA CTC ATC AGC ATG GCC TAC GGG CAG ATT  G GTGAGGCACCGGGGA . . . . . . . . . .  in t ron  18 .... 
Lys -Leu-Va l -Asn-G lu -Arg -Leu- I le -Ser -Met -A la -Tyr -G ly -G ln - I le -G( ly )  
. . . . . .  CTCTCCTCCTTCCAG GA ATG ATC CAG GCT CTC GGT GGC TTC TTC TCT TAC TTT  GTG ATC CTG GCA GAA AAT GGC 
(G)•y -Met - I•e -G•n-A•a-Leu-G•y-G•y-Phe-Phe-Ser -Tyr -Phe-Va•- I•e -Leu-A•a-G•u-Asn-G•y-  
TTC TTG CCC GGC AAC CTG GTG GGC ATC CGG CTG AAC TGG GAT GAC CGC ACC GTC AAT GAC CTG GAA GAC AGT TAC 
Phe-Leu-Pr• -G•y-Asn-Leu-•a•-G•y- I•e -Arg -Leu-Asn-Trp -Asp-Asp-Arg -Thr -Va•-Asn-Asp-Leu-G•u-Asp-Ser -Tyr -  
GGG CAG CAG TGG GTGAGTAGGGCAGGG . . . . . . . . .  in t ron  19 . . . . . . . . . .  TCACCGCTCCTGCAG ACA TAC GAG CAG AGG AAG GTG 
G ly -G ln -G ln -Trp  Thr -Tyr -G lu -G ln -Arg -Lys -Va l -  
GTG GAG TTC ACC TGC CAC ACG GCC TTC TTT  GTG AGC ATC GTT GTC GTC CAG TGG GCC GAT CTG ATC ATC TGC AAG 
•a•-G•u-Phe-Thr -Cys -H is -Thr -A•a-Phe-Phe-Va•-Ser - I•e -Va•-•a•-va•-G•n-Trp -A•a-Asp-Leu- I•e - I•e -Cys -Lys -  
ACC CGG AGG AAC TCG GTC TTC CAG CAG GGC ATG AA GTGAGGGCCGGGGGA . . . . . . . . . .  in t ron  20 . . . . . . . . .  CTTCTGTGC 
Thr -Arg -Arg -Asn-Ser -Va l -Phe-G ln -G ln -G ly -Met -Ly(s )  
CTCCAG G AAC AAG ATC CTG ATC TTC GGG CTG TTT  GAG GAG ACG GCC CTG GCT GCC TTC CTG TCC TAC TGC CCC GGA 
(Ly)s -Asn-Lys - I•e -Leu- I•e -Phe-G•y-Leu-Phe-G•u-G•u-Thr -A•a-Leu-A•a-A•a-Phe-Leu-ser -Tyr -Cys -Pr• -G•y-  
ATG GAC GTG GCC CTG CGC ATG TAC CCT CTC AA GTGAGTGCCCCGCTG . . . . . . . . . .  in t ron  21 . . . . . . . . . .  CTCTCCCCTCTG 
Met -Asp-Va l -A la -Leu-Arg -Met -Tyr -P ro -Leu-Ly(s )  
CAG G CCC AGC TGG TGG TTC TGT GCC TTC CCC TAC AGT TTC CTC ATC TTC GTC TAC GAC GAA ATC CGC AAA CTC ATC 
(Ly~s-Pr~-Ser -Trp -Tr~-Phe-C~s-A~a-Phe-Pr~-Tyr -Ser -Phe-Leu- I~e-Phe-Va~-Tyr -Asp-G~u- I~e-Arg -Lys -Leu- I~e-  
CTG CGC AGG AAC CCA GGG G GTGAGGGAGCTCGGC.~ . . . . . . . .  in t ron  22 (281b.p.)  . . . . . . . . . .  TCTTTGTCTCTCCAG GT TCG 
Leu-Arg -Arg -Asn-Pro -G ly -G( ly )  (G) !y -Trp -  
GTG GAG AAG GAAACC TAC TAC TGA CCTCAGCCCCACCACATCGCCCATCTCTTCCCCGTCCGCAGGCCAGGACCGCCCCTGTCAGTCCCCCCAA 






Fig.2. Nucleotide sequence and derived amino acid sequence of odIl-form of the human Na+,K+-ATPase catalytic subunit. Lengths 
of completed introns are in parentheses. On the left, numeration of nucleotides of the coding gene portion. The nucleotide sequence 
of 5 '-untranslated region and six nucleotides coding for the first two amino acids are shown on cDNA structure. Exon sequences 2-4 
and 14-23 of the gene are identical to sequences of cDNA independently determined. The 3 '-untranslated region is completed with 
the poly(A) tail attached to the site indicated with an arrow at G. Since AA* follows this G in the genome one cannot exclude that 
cleavage of the RNA-precursor occurs after any A. The regions of the amino acid sequence homologous to all the known ion- 
transporting ATPases are underlined. The proposed polyadenylation consensus equence is boxed. 
analysis of the secondary structure of hydrophilic 
and hydrophobic regions by Raman spectroscopy 
combined with predictional calculations [31] 
(fig.3). This comparison is correct due to the high 
homology of the primary structures and identity of 
the calculated secondary structures of variable por- 
tions of the cr and t~III polypeptides. The site of in- 
tron 1 falls into the polypeptide region, that is 
probably cleaved off during protein maturation as 
in the case of ot+-form [9] and therefore not 
shown in fig.3. 
It should be noted that as a rule introns are 
situated between the regions of the regular struc- 
ture or at their boundaries; however, e.g. introns 
11, 12 are in the g-structural stretch and intron 18 
is localized within the membrane u-helical rod V. 
Exon 8 encodes the hairpin structure including the 
III and IV transmembrane rods, other membrane 
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Table 1 
Consensus sequences of 5'-  and 3'-splice sites in Na÷,K+-ATPases gene (general consensus i from [15]) 
J une  1988 
5 ' -splice site 
Exon lntron 
G (%) 24 14 14 81 
A(%)  14 38 57 9 
U (%) 19 14 19 5 
C (%) 43 33 9 5 
Consensus - - A G 
General 
consensus A G - - U U - - 
3 '  -splice site 
Intron Exon 
100 0 86 14 90 38 33 33 
0 0 14 67 5 5 5 19 
0 100 0 9 5 24 19 14 
0 0 0 9 0 33 43 33 
G U G A G - - - 
G A A G 
G (%) 9 23 14 8 4 14 4 
A (%) 23 27 14 23 8 14 18. 
U (%) 23 9 27 23 46 23 36 
C (%) 45 41 46 46 41 50 41 
Consensus Y Y Y C Y 
General 
consensus 
8 14 23 27 8 4 0 27 0 0 
4 4 4 4 4 0 4 9 0 100 
41 14 55 23 32 18 46 9 14 0 
46 68 18 46 56 78 50 55 86 0 
Y C U Y C C Y C C A 
- Y Y Y Y Y Y Y Y Y Y N C A 
100 77 23 
0 9 18 
0 0 36 







segments are coded by exons 4,5,17,21 each. Posi- 
tions of some introns (4,8,17,20,21), which mark 
boundaries of these exons, coincide with those of 
hydrophobic sequences. The analogous ituation 
was first observed for the visual rhodopsin gene 
[32]. 
The preferable disposition of introns in the gene 
moiety encoding the protein surface regions is pro- 
posed in [27]. This is also true for the catalytic 
subunit of Na+,K+-ATPase: by immunochemical 
methods ome regions of its polypeptide chain are 
identified on the protein molecule surface 
N 
Fig.3. Model for spatial organization of Na +,K+-ATPase catalytic subunit (a-form) [31]. Cylinders and arrows correspond to t~-helical 
segments and H-pleated sheets, respectively. Encircled numbers indicate intron positions in veIII-form [9]. The amino acid residues 
within the enzyme active sites are specially indicated [28]. 
• 92  
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[27,28,30,34] and introns 2,4,7,19,22 are located in 
the corresponding gene parts. Besides, introns 2,7 
and 10 coincide well with characteristic points of 
primary limited proteolytic attacks of the native 
enzyme [35]. 
Numerous attempts have been undertaken to 
unravel the regularities underlying the structure of 
the nucleotide binding sites of different enzymes 
(review [36]). As mentioned above, in the animal 
EIE2-ATPases this site is evidently formed by con- 
servative regions of the polypeptide chain of the 
catalytic subunits in the cytoplasmic portion of the 
enzyme molecules. Analysis of these regions for 
the presence of permissive consensus equences 
[37] and characteristic elements of the secondary 
structure [38] may evidence that within the 
nucleotide-binding site of ion-transporting ATP- 
ases the B-a" structure (residues 240-265) encoded 
by the initial part of exon 8 is present in addition 
to the structure coded by the initial part of exon 
16-  a target for affinity modification with the 
ATP analogue [28,39-41]. The data concerning in- 
terrelations of intron positions and structural 
elements of the proposed nucleotide binding do- 
mains require thorough analysis and will be 
published. The study demonstrates certain correla- 
tions between structure-functional features of the 
protein and the exon-intron gene structure. Detail- 
ed knowledge of the Na+,K+-ATPase three- 
dimensional structure is necessary to prove 
whether the relationship exists between protein do- 
mains and gene exons. 
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